Rocket Lab tops Q2 revenue, lifts Q3 outlook amid ongoing losses

Rocket Lab reported Q2 CY2026 revenue of $234.1 million, up 62% year over year and beating estimates (consensus ≈$231.9M). GAAP loss was $0.08 per share, with Adjusted EBITDA margin at -3.8% and negative free cash flow of -$110.1 million; the company still narrowed losses and improved leverage. For Q3 CY2026, management guided to a midpoint revenue of $257.5 million and EBITDA of $20 million, above expectations of roughly $240.6 million and -$10.23 million, respectively, suggesting potential upside despite persistent losses. The stock traded about 1.8% lower after results, as investors weigh strong top-line guidance against continued profitability challenges.